Status: current, Defined. Date: 31-Jan 2016. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3487230014 | Product containing bismuth biskalcitrate and metronidazole and tetracycline (medicinal product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3713555019 | Bismuth biskalcitrate- and metronidazole- and tetracycline-containing product | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Bismuth biskalcitrate- and metronidazole- and tetracycline-containing product | Plays role | Antibacterial therapeutic role | true | Inferred relationship | Some | ||
| Bismuth biskalcitrate- and metronidazole- and tetracycline-containing product | Is a | Tetracycline-containing product | true | Inferred relationship | Some | ||
| Bismuth biskalcitrate- and metronidazole- and tetracycline-containing product | Is a | Metronidazole-containing product in oral dose form | false | Inferred relationship | Some | ||
| Bismuth biskalcitrate- and metronidazole- and tetracycline-containing product | Is a | Bismuth biskalcitrate-containing product | true | Inferred relationship | Some | ||
| Bismuth biskalcitrate- and metronidazole- and tetracycline-containing product | Has manufactured dose form | Oral dose form | false | Inferred relationship | Some | ||
| Bismuth biskalcitrate- and metronidazole- and tetracycline-containing product | Has active ingredient | Metronidazole | true | Inferred relationship | Some | 1 | |
| Bismuth biskalcitrate- and metronidazole- and tetracycline-containing product | Has active ingredient | Tetracycline | true | Inferred relationship | Some | 2 | |
| Bismuth biskalcitrate- and metronidazole- and tetracycline-containing product | Has active ingredient | Bismuth biskalcitrate | true | Inferred relationship | Some | 3 | |
| Bismuth biskalcitrate- and metronidazole- and tetracycline-containing product | Is a | Tetracycline-containing product in oral dose form | false | Inferred relationship | Some | ||
| Bismuth biskalcitrate- and metronidazole- and tetracycline-containing product | Is a | Metronidazole-containing product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Bismuth biskalcitrate and metronidazole and tetracycline only product | Is a | True | Bismuth biskalcitrate- and metronidazole- and tetracycline-containing product | Inferred relationship | Some | |
| Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline 125 mg oral capsule | Is a | False | Bismuth biskalcitrate- and metronidazole- and tetracycline-containing product | Inferred relationship | Some | |
| Bismuth biskalcitrate- and metronidazole- and tetracycline-containing product in oral dose form | Is a | True | Bismuth biskalcitrate- and metronidazole- and tetracycline-containing product | Inferred relationship | Some |
This concept is not in any reference sets
FHIR